Arcturus Therapeutics Holdings Inc. (the "Company", "Arcturus", Nasdaq: ARCT), a commercial messenger RNA medicines company ...
SAN DIEGO--(BUSINESS WIRE)--Arcturus Therapeutics Holdings Inc. (the “Company”, “Arcturus”, Nasdaq: ARCT), a commercial messenger RNA medicines company focused on the development of ...
Twist Bioscience focuses on synthetic DNA manufacturing, leveraging its proprietary silicon-based platform. Find out why I'm ...
Prof Choo said the facility has started working on the pre-clinical RNA samples for the development of mRNA vaccines against influenza outbreaks, including the H5N1 bird flu strain. Researchers can ...
HONOLULU (HawaiiNewsNow) - Hawaii is the only state that hasn’t reported a case of H5N1, but that might change after an ...
As the H5N1 avian influenza virus continues its rampage through ... A flu virus’s genetic material is made up of eight RNA ...
“We started to see H5N1 signal in March 2024 and we were both very shocked ... “If you were to just extract RNA and DNA from ...
SAN DIEGO--(BUSINESS WIRE)--$ARCT #ClinicalTrial--Arcturus Therapeutics Holdings Inc. (the “Company”, “Arcturus”, Nasdaq: ARCT), a commercial messenger RNA ...